Important Decrease in Hospitalizations for Acute Diabetes Events Following FreeStyle Libre System Initiation in People with Type 2 Diabetes on Basal Insulin Therapy in France-Reference-Cited by-同舟云学术

Important Decrease in Hospitalizations for Acute Diabetes Events Following FreeStyle Libre System Initiation in People with Type 2 Diabetes on Basal Insulin Therapy in France

Published:2023-01-01 Issue:1 Volume:25 Page:20-30
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Guerci Bruno¹,Roussel Ronan²³,Levrat-Guillen Fleur⁴,Detournay Bruno⁵^ORCID,Vicaut Eric⁶,De Pouvourville Gérard⁷,Emery Corinne⁵,Riveline Jean-Pierre⁸⁹

Affiliation:

1. Department of Endocrinology, Diabetology, and Nutrition, Brabois Adult Hospital, University of Lorraine, Vandoeuvre-lès-Nancy, France.

2. Institut Necker Enfants Malades (INEM), Unité INSERM U1151 INEM, IMMEDIAB Laboratory, Paris, France.

3. Department of Diabetology and Endocrinology, Lariboisière Hospital, Paris, France.

4. Abbott Laboratories, Maidenhead, United Kingdom.

5. CEMKA, Bourg-la-Reine, France.

6. Clinical Research Unit, Fernand Vidal Hospital, Paris, France.

7. Department of Economics, ESSEC Business School, Cergy-Pontoise, France.

8. Department of Endocrinology and Diabetology, Lariboisière Hospital, Paris, France.

9. Institut Necker Enfants Malades, INSERM U1151, CNRS UMR 8253, IMMEDIAB Laboratory, Paris, France.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/dia.2022.0271

Reference35 articles.

1. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial

2. Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial

3. Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes

4. Reductions in HbA1c with Flash Glucose Monitoring Are Sustained for up to 24 Months: A Meta-Analysis of 75 Real-World Observational Studies

5. Improving HbA1c Control in Type 1 or Type 2 Diabetes Using Flash Glucose Monitoring: A Retrospective Observational Analysis in Two German Centres

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced hybrid closed loop (artificial pancreas) and carbohydrate count in type 1 diabetes;Mediterranean Journal of Nutrition and Metabolism;2024-09-13

2. L’avenir des traitements du diabète;Soins;2024-09

3. Continuous glucose monitoring for self-management of diabetes in people living with type 2 diabetes mellitus on basal insulin therapy: A microsimulation model and cost-effectiveness analysis from a US perspective with relevance to Medicaid;Journal of Managed Care & Specialty Pharmacy;2024-09

4. Diabetes Management in Transition: Market Insights and Technological Advancements in CGM and Insulin Delivery;Advanced Sensor Research;2024-07-11

5. Glycemic Risk Index in a Cohort of Patients with Type 1 Diabetes Mellitus Stratified by the Coefficient of Variation: A Real-Life Study;Diabetes Technology & Therapeutics;2024-07-10